SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-085868
Filing Date
2021-03-18
Accepted
2021-03-18 16:36:53
Documents
5
Period of Report
2021-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d112683ddef14a.htm DEF 14A 1460403
2 GRAPHIC g112683g0315212854430.jpg GRAPHIC 2591
3 GRAPHIC g112683g10v55.jpg GRAPHIC 30818
4 GRAPHIC g112683g16f81.jpg GRAPHIC 24487
5 GRAPHIC g112683g69b62.jpg GRAPHIC 37433
  Complete submission text file 0001193125-21-085868.txt   1587196
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 21754833
SIC: 2834 Pharmaceutical Preparations